vs
AVADEL PHARMACEUTICALS PLC(AVDL)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是AVADEL PHARMACEUTICALS PLC的1.0倍($78.6M vs $77.5M),AVADEL PHARMACEUTICALS PLC净利率更高(0.0% vs -178.3%,领先178.3%),AVADEL PHARMACEUTICALS PLC同比增速更快(54.9% vs 0.4%),Repay Holdings Corp自由现金流更多($23.2M vs $22.2M),过去两年AVADEL PHARMACEUTICALS PLC的营收复合增速更高(99.6% vs -1.3%)
Avadel Pharmaceuticals是爱尔兰的专科制药企业,专注于睡眠障碍治疗药物的研发,产品覆盖医院及基层医疗场景,总部位于爱尔兰都柏林,在美国密苏里州圣路易斯、法国里昂均设有业务运营点。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
AVDL vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.0倍
$77.5M
营收增速更快
AVDL
高出54.5%
0.4%
净利率更高
AVDL
高出178.3%
-178.3%
自由现金流更多
RPAY
多$1.0M
$22.2M
两年增速更快
AVDL
近两年复合增速
-1.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $77.5M | $78.6M |
| 净利润 | $20.0K | $-140.1M |
| 毛利率 | — | 74.2% |
| 营业利润率 | 2.5% | -182.2% |
| 净利率 | 0.0% | -178.3% |
| 营收同比 | 54.9% | 0.4% |
| 净利润同比 | 100.8% | -3304.1% |
| 每股收益(稀释后) | $0.00 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AVDL
RPAY
| Q4 25 | — | $78.6M | ||
| Q3 25 | $77.5M | $77.7M | ||
| Q2 25 | $68.1M | $75.6M | ||
| Q1 25 | $52.5M | $77.3M | ||
| Q4 24 | $50.4M | $78.3M | ||
| Q3 24 | $50.0M | $79.1M | ||
| Q2 24 | $41.5M | $74.9M | ||
| Q1 24 | $27.2M | $80.7M |
净利润
AVDL
RPAY
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $20.0K | $-6.4M | ||
| Q2 25 | $9.7M | $-102.3M | ||
| Q1 25 | $-4.9M | $-7.9M | ||
| Q4 24 | $-5.0M | $-4.1M | ||
| Q3 24 | $-2.6M | $3.2M | ||
| Q2 24 | $-13.8M | $-4.1M | ||
| Q1 24 | $-27.3M | $-5.2M |
毛利率
AVDL
RPAY
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | 90.7% | 75.7% | ||
| Q1 25 | 89.4% | 75.9% | ||
| Q4 24 | 90.5% | 76.3% | ||
| Q3 24 | 87.7% | 77.8% | ||
| Q2 24 | 93.3% | 78.2% | ||
| Q1 24 | 94.4% | 76.2% |
营业利润率
AVDL
RPAY
| Q4 25 | — | -182.2% | ||
| Q3 25 | 2.5% | -3.9% | ||
| Q2 25 | 13.0% | -138.7% | ||
| Q1 25 | -5.7% | -4.7% | ||
| Q4 24 | -6.5% | -1.5% | ||
| Q3 24 | -0.7% | -0.9% | ||
| Q2 24 | -30.7% | -4.6% | ||
| Q1 24 | -95.8% | -3.1% |
净利率
AVDL
RPAY
| Q4 25 | — | -178.3% | ||
| Q3 25 | 0.0% | -8.3% | ||
| Q2 25 | 14.2% | -135.2% | ||
| Q1 25 | -9.4% | -10.3% | ||
| Q4 24 | -10.0% | -5.3% | ||
| Q3 24 | -5.2% | 4.1% | ||
| Q2 24 | -33.3% | -5.4% | ||
| Q1 24 | -100.6% | -6.5% |
每股收益(稀释后)
AVDL
RPAY
| Q4 25 | — | $-1.68 | ||
| Q3 25 | $0.00 | $-0.08 | ||
| Q2 25 | $0.10 | $-1.15 | ||
| Q1 25 | $-0.05 | $-0.09 | ||
| Q4 24 | $-0.04 | $-0.04 | ||
| Q3 24 | $-0.03 | $0.03 | ||
| Q2 24 | $-0.14 | $-0.04 | ||
| Q1 24 | $-0.30 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $91.6M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $98.2M | $484.4M |
| 总资产 | $199.4M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
AVDL
RPAY
| Q4 25 | — | $115.7M | ||
| Q3 25 | $91.6M | $95.7M | ||
| Q2 25 | $81.5M | $162.6M | ||
| Q1 25 | $66.5M | $165.5M | ||
| Q4 24 | $73.8M | $189.5M | ||
| Q3 24 | $65.8M | $168.7M | ||
| Q2 24 | $71.4M | $147.1M | ||
| Q1 24 | $88.8M | $128.3M |
总债务
AVDL
RPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益
AVDL
RPAY
| Q4 25 | — | $484.4M | ||
| Q3 25 | $98.2M | $616.9M | ||
| Q2 25 | $90.7M | $633.7M | ||
| Q1 25 | $74.1M | $755.7M | ||
| Q4 24 | $73.8M | $761.3M | ||
| Q3 24 | $74.7M | $754.7M | ||
| Q2 24 | $70.3M | $815.4M | ||
| Q1 24 | $78.4M | $813.8M |
总资产
AVDL
RPAY
| Q4 25 | — | $1.2B | ||
| Q3 25 | $199.4M | $1.3B | ||
| Q2 25 | $187.2M | $1.4B | ||
| Q1 25 | $167.9M | $1.5B | ||
| Q4 24 | $164.2M | $1.6B | ||
| Q3 24 | $158.3M | $1.6B | ||
| Q2 24 | $157.5M | $1.5B | ||
| Q1 24 | $167.9M | $1.5B |
负债/权益比
AVDL
RPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $22.2M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $22.2M | $23.2M |
| 自由现金流率自由现金流/营收 | 28.7% | 29.6% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | 1110.25× | — |
| 过去12个月自由现金流最近4个季度 | — | $90.7M |
8季度趋势,按日历期对齐
经营现金流
AVDL
RPAY
| Q4 25 | — | $23.3M | ||
| Q3 25 | $22.2M | $32.2M | ||
| Q2 25 | $12.7M | $33.1M | ||
| Q1 25 | $-8.2M | $2.5M | ||
| Q4 24 | $7.9M | $34.3M | ||
| Q3 24 | $-6.9M | $60.1M | ||
| Q2 24 | $-18.2M | $31.0M | ||
| Q1 24 | $-29.7M | $24.8M |
自由现金流
AVDL
RPAY
| Q4 25 | — | $23.2M | ||
| Q3 25 | $22.2M | $32.1M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | — | $59.8M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $24.7M |
自由现金流率
AVDL
RPAY
| Q4 25 | — | 29.6% | ||
| Q3 25 | 28.7% | 41.3% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 30.6% |
资本支出强度
AVDL
RPAY
| Q4 25 | — | 0.1% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.1% |
现金转化率
AVDL
RPAY
| Q4 25 | — | — | ||
| Q3 25 | 1110.25× | — | ||
| Q2 25 | 1.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVDL
暂无分部数据
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |